PRAI (PrivaseaAI) fluctuated 42.2% in 24 hours: Low liquidity trading amplified small price swings
Bitget Pulse2026/05/04 09:10Volatility Overview
In the past 24 hours, PRAI price rebounded from a low of $0.00116 to a high of $0.00165, currently at $0.00165, with a price swing of 42.2%. The 24-hour trading volume is roughly $137,600, and low liquidity makes the price easily influenced by trading activity.
Brief Analysis of the Cause of Fluctuation
- No official announcements, major news, or significant on-chain whale transfers were found in the past 24 hours.
- The volatility mainly stems from market speculation in a low market cap (circulating supply of approximately 312 million) environment with low trading volume. Trading on DEXs (such as BSC PancakeSwap) amplifies price sensitivity.
Market Opinions and Outlook
X platform trading signals indicate a short-term bullish bias, suggesting going long near the $0.001202 support with a target of $0.00144, but emphasizing a bearish turn if it breaks below $0.00111. Community discussions are limited; mainstream forecasts expect a slight increase to $0.00118–$0.00119 in May 2026. Risk warning: low liquidity could result in price pullbacks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring. For informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Stan Druckenmiller backs trade.xyz, ICE partnership targets US perpetual futures
Record High Monthly Active Users Can't Hide Risks: Pinterest (PINS.US) Q3 Revenue and Profit Both Miss Expectations, Q4 Guidance Weak, Shares Drop Over 10% After Hours
Pinterest (PINS.US), the image-based social networking and shopping platform, released its Q3 2026 financial report on Thursday, October 29 local time. Although global monthly active users (MAU) reached a historic high of 661 million and net sales achieved double-digit growth, both the company's revenue and adjusted profit for the quarter fell short of Wall Street expectations.
Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare
On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.